National Politics
On Selma's 50th anniversary, Obama will look to the future

Topics

Hepatitis
California lawmakers target $1,000 hepatitis pill, other costly drugs
California lawmakers target $1,000 hepatitis pill, other costly drugs

California lawmakers are joining the national debate over what effect high-priced specialty drugs are having on medical costs for consumers and taxpayers. A hearing Wednesday led by state Sen. Ed Hernandez (D-West Covina) is expected to feature testimony from an executive at Gilead Sciences Inc. about Sovaldi, the company's $1,000-per-pill hepatitis C drug that has drawn criticism from members of Congress, Medicaid officials and health insurers. The Senate Health Committee said it's looking into the factors driving up medical costs and what can be done to keep health insurance premiums affordable for consumers. A 12-week course of Sovaldi costs about $84,000. Gilead also...

Loading